Neuroone Medical Technologies (NMTC) Return on Capital Employed Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 2,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,902.00 |
| Dec 31, 2025 | 14.00 |
| Sep 30, 2025 | 6,053.00 |
| Jun 30, 2025 | 253.00 |
| Mar 31, 2025 | -9,934.00 |
| Dec 31, 2024 | -6,093.00 |
| Sep 30, 2024 | -27,313.00 |
| Jun 30, 2024 | -27,730.00 |
| Mar 31, 2024 | -25,017.00 |
| Dec 31, 2023 | 315,751.00 |
| Sep 30, 2023 | -1,544.00 |
| Jun 30, 2023 | -33,539.00 |
| Mar 31, 2023 | -28,739.00 |
| Dec 31, 2022 | -21,275.00 |
| Sep 30, 2022 | -91,338.00 |
| Jun 30, 2022 | 220,479.00 |
| Mar 31, 2022 | -90,182.00 |
| Jun 30, 2021 | -20,447.00 |
| Mar 31, 2021 | -14,500.00 |
| Dec 31, 2020 | -348,495.00 |
| Dec 31, 2019 | 5,112.00 |
| Sep 30, 2019 | 76,900.00 |
| Jun 30, 2019 | -232,831.00 |
| Mar 31, 2019 | 78,324.00 |
| Dec 31, 2016 | -1,223.00 |
| Sep 30, 2016 | -5,135.00 |
| Jun 30, 2016 | -7,077.00 |
| Mar 31, 2016 | -1,747.00 |